People are dying from coronavirus because we’re not fast enough at clinical research
ADOBE
Our inability to start and run clinical trials faster — whether in a pandemic or not — is a legacy of our decision not to develop the right technologies.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario